Roberts R - Search Results

1

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.

Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. Noseworthy JH, et al. Among authors: roberts r. Neurology. 1994 Jan;44(1):16-20. doi: 10.1212/wnl.44.1.16. Neurology. 1994. PMID: 8290055 Clinical Trial.

2

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article].

Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. Noseworthy JH, et al. Among authors: roberts r. Neurology. 2001 Dec;57(12 Suppl 5):S31-5. Neurology. 2001. PMID: 11902593 No abstract available.

3

Cyclophosphamide and plasma exchange in multiple sclerosis.

Noseworthy JH, Vandervoort MK, Penman M, Ebers G, Shumak K, Seland TP, Roberts R, Yetisir E, Gent M, Taylor DW. Noseworthy JH, et al. Among authors: roberts r. Lancet. 1991 Jun 22;337(8756):1540-1. doi: 10.1016/0140-6736(91)93226-y. Lancet. 1991. PMID: 1675382 No abstract available.

4

Cyclophosphamide and MS.

Noseworthy JH, Ebers GC, Roberts R. Noseworthy JH, et al. Among authors: roberts r. Neurology. 1994 Mar;44(3 Pt 1):579-81. doi: 10.1212/wnl.44.3_part_1.579. Neurology. 1994. PMID: 8145943 No abstract available.

5

Cladribine: an investigational immunomodulatory agent for multiple sclerosis.

Brousil JA, Roberts RJ, Schlein AL. Brousil JA, et al. Ann Pharmacother. 2006 Oct;40(10):1814-21. doi: 10.1345/aph.1H037. Epub 2006 Sep 19. Ann Pharmacother. 2006. PMID: 16985095 Review.

6

Predicting bullying victimization among adolescents using the risk and protective factor framework: a large-scale machine learning approach.

Low E, Monsen J, Schow L, Roberts R, Collins L, Johnson H, Hanson CL, Snell Q, Tass ES. Low E, et al. Among authors: roberts r. BMC Public Health. 2025 Jan 25;25(1):321. doi: 10.1186/s12889-025-21521-0. BMC Public Health. 2025. PMID: 39863846 Free PMC article.

7

AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility.

Zardab M; Barts Pancreas Tissue Bank; Grose RP, Kocher HM. Zardab M, et al. Sci Rep. 2025 Jan 23;15(1):2934. doi: 10.1038/s41598-025-87337-5. Sci Rep. 2025. PMID: 39849106 Free PMC article.

8

Is ChatGPT ready for public use in organ-specific drug toxicity research?

Connor S, Wu L, Roberts RA, Tong W. Connor S, et al. Among authors: roberts ra. Drug Discov Today. 2025 Jan 20:104297. doi: 10.1016/j.drudis.2025.104297. Online ahead of print. Drug Discov Today. 2025. PMID: 39842505

9

Lymph node silicosis and recurrent tuberculosis in a short service goldminer.

Knight D, Murray J, Roberts R, Ehrlich R. Knight D, et al. Among authors: roberts r. Occup Med (Lond). 2025 Jan 21:kqae135. doi: 10.1093/occmed/kqae135. Online ahead of print. Occup Med (Lond). 2025. PMID: 39836638 No abstract available.

10

Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2.

Kocher HM; BCI-STARPAC2 team; BPTB team; Precision-Panc team; Sasieni P, Corrie P, McNamara MG, Sarker D, Froeling FEM, Christie A, Gillmore R, Khan K, Propper D. Kocher HM, et al. BMC Cancer. 2025 Jan 20;25(1):106. doi: 10.1186/s12885-024-13333-z. BMC Cancer. 2025. PMID: 39833722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,911 results

Search Page

Filters